Activation of human eosinophils by chemokines

Chemical Immunology

Volumn 76, Issue , 2000, Pages 177-207

  Elsner, Jörn ^a   Kapp, Alexander ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPHYLATOXIN; CELL SURFACE MARKER; CHEMOKINE; CHEMOKINE RECEPTOR; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; F ACTIN; G ACTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 8; REACTIVE OXYGEN METABOLITE;

AMINO TERMINAL SEQUENCE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CHEMOTAXIS; CHROMOSOME 2; CYTOSKELETON; EFFECTOR CELL; EOSINOPHIL; EXTRACELLULAR MATRIX; GENE MAPPING; HUMAN; INFLAMMATION; MAST CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY BURST; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0034097657     PISSN: 10150145     EISSN: None     Source Type: Journal    
DOI: 10.1159/000058786     Document Type: Review

References (11)

1. Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445.
2. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998;392:565-568.
3. Eisner J, Kapp A: Regulation and modulation of eosinophil effector functions. Allergy 1999;54: 15-26.
4. Horuk R: Chemokine receptors and HIV-1: The fusion of two major research fields. Immunol. Today 1999;20:89-94.
5. Oberlin E, Amara A, Bachelierie F, Bessia C, Virelizier JL, Seisdedos F, Schwartz O, Heard JM, Clark Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/7fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996; 382:833-835.
6. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382:722-725.
7. Bates P: Chemokine receptors and HIV-1: An attractive pair? Cell 1996;86:1-3.
8. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J: The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996;85:1135-1148.
9. Doranz BJ, Rucker J, Yi Y, Smyth RJ, Samson M, Peiper SC, Parmentier M, Collman RG, Doms RW: A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-1158.
10. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-I infection. Cell 1996;86:367-377.
11. Hadida F, Vieillard V, Autran B, dark-Lewis I, Baggiolini M, Debre P: HIV-specific T cell cytotoxicity mediated by RANTES via the chemokine receptor CCR3. J Exp Med 1998;188:609-614.